Thunen Shelley B

Director, See remarks, Chief Financial Officer, EVP & CFO, CFO, Treasurer & Asst. Sec'ty · SEC CIK 1297491
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$9.62M
104 trades
Net flow
−$9.62M
Net selling
Total filings
130
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
RXST
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −11%

Thunen Shelley B sold $249.4K of RXST, trimming their stake 11%.

−$249.4K
5,201 sh @ $48
RXST
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −24%

Thunen Shelley B sold $463.6K of RXST, trimming their stake 24%.

−$463.6K
9,521 sh @ $49
RXST
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −0.9%

Thunen Shelley B sold $13.7K of RXST, trimming their stake 1%.

−$13.7K
278 sh @ $49
Advertisement
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed Jul 2, 2024 ΔOwn +72%
+$156K
10,000 sh @ $16
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −34%

Thunen Shelley B sold $475.8K of RXST, trimming their stake 34%.

−$475.8K
8,146 sh @ $58
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −12%

Thunen Shelley B sold $110.3K of RXST, trimming their stake 12%.

−$110.3K
1,854 sh @ $59
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −79%

Thunen Shelley B sold $386.4K of RXST, trimming their stake 79%.

−$386.4K
6,599 sh @ $59
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −100%

Thunen Shelley B sold $107.4K of RXST, trimming their stake 100%.

−$107.4K
1,803 sh @ $60
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed May 2, 2024 ΔOwn +75%
+$159.8K
10,247 sh @ $16
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed May 2, 2024 ΔOwn −40%

Thunen Shelley B sold $506.8K of RXST, trimming their stake 40%.

−$506.8K
9,620 sh @ $53
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed May 2, 2024 ΔOwn −2.7%

Thunen Shelley B sold $20.2K of RXST, trimming their stake 3%.

−$20.2K
380 sh @ $53
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −31%

Thunen Shelley B sold $441.2K of RXST, trimming their stake 31%.

−$441.2K
8,857 sh @ $50
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −4.1%

Thunen Shelley B sold $40.2K of RXST, trimming their stake 4%.

−$40.2K
800 sh @ $50
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −48%

Thunen Shelley B sold $445.2K of RXST, trimming their stake 48%.

−$445.2K
8,938 sh @ $50
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −6.8%

Thunen Shelley B sold $33.3K of RXST, trimming their stake 7%.

−$33.3K
662 sh @ $50
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −2.2%

Thunen Shelley B sold $10.1K of RXST, trimming their stake 2%.

−$10.1K
200 sh @ $50
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −6.1%

Thunen Shelley B sold $28K of RXST, trimming their stake 6%.

−$28K
543 sh @ $52
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed Mar 5, 2024 ΔOwn +73%
+$156K
10,000 sh @ $16
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −4.9%

Thunen Shelley B sold $64.1K of RXST, trimming their stake 5%.

−$64.1K
1,166 sh @ $55
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −28%

Thunen Shelley B sold $358.6K of RXST, trimming their stake 28%.

−$358.6K
6,361 sh @ $56
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −15%

Thunen Shelley B sold $141K of RXST, trimming their stake 15%.

−$141K
2,473 sh @ $57
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed Feb 7, 2024 ΔOwn +116%
+$237.3K
15,875 sh @ $15
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Feb 7, 2024 ΔOwn −54%

Thunen Shelley B sold $753.6K of RXST, trimming their stake 54%.

−$753.6K
15,875 sh @ $47
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed Feb 7, 2024 ΔOwn +102%
+$29.9K
6,900 sh @ $4
RXST
Option exercise Thunen Shelley B · Chief Financial Officer · Option exercise · filed Feb 7, 2024 ΔOwn +67%
+$136.4K
9,125 sh @ $15
RXST
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Feb 7, 2024 ΔOwn −40%

Thunen Shelley B sold $429.1K of RXST, trimming their stake 40%.

−$429.1K
9,125 sh @ $47

Frequently asked questions

How is Thunen Shelley B's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Thunen Shelley B's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.